Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › KY › Berea › NPI 1740488386
Hospital

Saint Joseph Health System, INC

Saint Joseph Health System, INC was paid $29.77M by Medicaid between Jan 2018 and Dec 2024, across 251 billing codes. Its largest line is 99284, emergency room visit (serious) — 15% of everything it billed.

33Billing provider infoSAINT JOSEPH HEALTH SYSTEM, INC
BEREA, KY 40403
33aNPI1740488386assigned 07/05/2007
33bProvider typeCritical Access Hospital
28Total paid$29.77M
24GClaims588,017
24DCodes billed251
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Kentucky

Rank by total paid#3 of 16
Median peer was paid$11.73M
This provider vs. median2.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201889,430$4.55M
201992,657$4.25M
202084,466$3.66M
202191,170$4.32M
202281,705$4.20M
202381,663$4.42M
2024incomplete66,926$4.38M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 15% 20,694 15,312 $4.45M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 12% 27,337 23,217 $3.51M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 8.6% 10,909 7,169 $2.56M
74176 Computed tomography, abdomen and pelvis; without contrast material 5.0% 5,544 4,483 $1.49M
96375 Therapeutic injection; each additional sequential IV push 3.2% 11,884 9,253 $952K
80053 Comprehensive metabolic panel 3.0% 27,324 22,058 $906K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 2.9% 14,983 4,644 $853K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.6% 19,160 10,470 $766K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.6% 2,529 2,208 $761K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.9% 8,804 7,001 $560K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.7% 1,343 1,103 $511K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.7% 12,125 3,106 $506K
239 more codes
70450 Computed tomography, head or brain; without contrast material 1.7% 3,392 $495K
36415 Collection of venous blood by venipuncture 1.7% 73,211 $494K
71046 Radiologic examination, chest; 2 views 1.6% 8,127 $482K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.5% 3,988 $460K
71045 Radiologic examination, chest; single view 1.5% 9,839 $439K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.4% 25,964 $425K
96361 Intravenous infusion, hydration; each additional hour 1.3% 13,489 $388K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1.0% 9,215 $307K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.0% 795 $301K
96376 <1% 3,449 $268K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 4,253 $261K
74018 <1% 4,544 $238K
87086 Culture, bacterial; quantitative colony count, urine <1% 10,561 $236K
83690 <1% 9,116 $218K
84484 <1% 7,837 $208K
73564 <1% 2,106 $195K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,113 $187K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,380 $185K
81001 <1% 15,525 $174K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,302 $174K
84443 Thyroid stimulating hormone (TSH) <1% 5,217 $170K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,173 $161K
73630 <1% 2,368 $158K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 2,240 $157K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 4,892 $154K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,954 $149K
73610 <1% 1,978 $143K
73030 <1% 2,012 $139K
72100 <1% 1,893 $138K
73130 <1% 1,763 $134K
83880 <1% 1,644 $120K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 4,532 $119K
81025 <1% 6,526 $113K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 1,840 $112K
87040 <1% 2,430 $110K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 1,848 $108K
80061 Lipid panel <1% 4,044 $103K
83520 <1% 1,787 $102K
83735 <1% 4,701 $101K
80048 Basic metabolic panel (calcium, ionized) <1% 6,757 $101K
52356 <1% 105 $96K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,414 $96K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 2,426 $91K
71275 Computed tomographic angiography, chest, with contrast material <1% 382 $89K
85027 <1% 6,885 $88K
83605 <1% 3,619 $86K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 185 $79K
J1212 Injection, dmso, dimethyl sulfoxide, 50%, 50 ml <1% 204 $78K
73110 <1% 1,105 $75K
G0283 Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care <1% 4,370 $66K
71271 <1% 433 $66K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 1,041 $66K
87186 <1% 2,348 $63K
84145 <1% 686 $60K
71250 <1% 466 $59K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,170 $59K
87081 <1% 3,005 $58K
Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml <1% 1,560 $57K
85610 <1% 3,903 $55K
97162 <1% 803 $52K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,113 $51K
84439 <1% 2,673 $48K
G0378 Hospital observation service, per hour <1% 292 $47K
85379 <1% 1,853 $46K
76536 <1% 252 $42K
76000 <1% 816 $41K
93017 <1% 389 $41K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,809 $41K
93971 <1% 182 $39K
83036 Hemoglobin; glycosylated (A1C) <1% 2,269 $39K
72125 Computed tomography, cervical spine; without contrast material <1% 249 $38K
G0410 Group psychotherapy other than of a multiple-family group, in a partial hospitalization or intensive outpatient setting, approximately 45 to 50 minutes <1% 532 $38K
29125 <1% 428 $37K
86140 <1% 2,494 $35K
73502 <1% 528 $35K
72040 <1% 434 $32K
12001 <1% 200 $32K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 233 $32K
82150 <1% 1,617 $31K
80074 <1% 366 $31K
C1769 Guide wire <1% 678 $28K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,766 $26K
84481 <1% 973 $24K
82962 <1% 2,115 $23K
81003 <1% 4,959 $23K
82607 <1% 986 $23K
87522 Neg quan hep c or qual rna <1% 210 $23K
85730 <1% 845 $22K
82570 <1% 1,400 $21K
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser <1% 264 $21K
72131 <1% 125 $20K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 72 $19K
52332 <1% 26 $19K
J7030 Infusion, normal saline solution , 1000 cc <1% 4,008 $19K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 10,176 $18K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 338 $18K
85652 <1% 550 $17K
85651 <1% 1,526 $17K
52260 <1% 47 $17K
90715 <1% 594 $17K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 104 $15K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 239 $15K
97535 Self-care/home management training, each 15 minutes <1% 292 $15K
0240U <1% 647 $15K
87420 <1% 517 $15K
80050 General health panel <1% 346 $14K
86701 <1% 259 $14K
96367 <1% 168 $13K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 674 $13K
J1170 Injection, hydromorphone, up to 4 mg <1% 4,057 $13K
52224 <1% 14 $13K
82805 <1% 324 $12K
J2704 Injection, propofol, 10 mg <1% 3,199 $12K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 369 $12K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 604 $11K
95806 <1% 53 $11K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,493 $11K
87070 <1% 519 $11K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 76 $10K
82043 <1% 378 $10K
87077 <1% 467 $10K
J2270 Injection, morphine sulfate, up to 10 mg <1% 2,876 $10K
C2617 Stent, non-coronary, temporary, without delivery system <1% 138 $10K
73080 <1% 220 $9K
Q3014 Telehealth originating site facility fee <1% 648 $9K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 46 $8K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 1,376 $8K
97161 <1% 116 $8K
83540 <1% 467 $8K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 61 $8K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 14 $8K
29515 <1% 105 $8K
71101 <1% 100 $8K
10060 <1% 81 $8K
52214 <1% 12 $7K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 47 $6K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 553 $6K
74022 <1% 65 $6K
73090 <1% 86 $6K
82550 <1% 300 $6K
77063 Screening digital breast tomosynthesis, bilateral <1% 244 $6K
J2550 Injection, promethazine hcl, up to 50 mg <1% 2,917 $6K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 2,124 $6K
J3490 Unclassified drugs <1% 438 $6K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 84 $5K
78227 <1% 27 $5K
76830 Ultrasound, transvaginal <1% 25 $5K
83550 <1% 267 $5K
82140 <1% 135 $5K
82728 <1% 150 $5K
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg <1% 1,406 $4K
80076 <1% 215 $4K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 15 $4K
J2785 Injection, regadenoson, 0.1 mg <1% 29 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 1,520 $4K
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 48 $4K
J3370 Injection, vancomycin hcl, 500 mg <1% 289 $4K
C9113 Injection, pantoprazole sodium, per vial <1% 934 $3K
J3475 Injection, magnesium sulfate, per 500 mg <1% 376 $3K
87486 <1% 137 $3K
72072 <1% 45 $3K
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 184 $3K
94760 <1% 274 $3K
84702 <1% 71 $3K
J0561 Injection, penicillin g benzathine, 100,000 units <1% 29 $3K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,207 $2K
86038 <1% 90 $2K
93000 <1% 92 $2K
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 1,144 $2K
J2060 Injection, lorazepam, 2 mg <1% 759 $2K
87581 <1% 83 $2K
36416 <1% 247 $2K
36600 <1% 96 $2K
82948 <1% 355 $2K
82947 <1% 542 $2K
72110 <1% 24 $2K
73562 <1% 32 $2K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 83 $2K
73590 <1% 32 $2K
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 636 $2K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 36 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 625 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 14 $2K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 36 $1K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 43 $1K
97116 <1% 31 $1K
83516 <1% 26 $1K
82803 <1% 13 $1K
J2919 Injection, methylprednisolone sodium succinate, 5 mg <1% 111 $1K
84153 <1% 25 $983.10
J2720 Injection, protamine sulfate, per 10 mg <1% 49 $972.19
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 26 $859.16
97163 <1% 12 $815.51
86200 <1% 27 $808.46
29505 <1% 14 $764.13
99213 Doctor's office visit, returning patient (routine) <1% 13 $758.65
86431 <1% 56 $754.11
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 68 $711.04
84550 <1% 53 $673.79
80320 <1% 14 $635.07
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals <1% 358 $581.74
82553 <1% 22 $536.19
82746 <1% 30 $535.63
80143 <1% 13 $519.51
J7120 Ringers lactate infusion, up to 1000 cc <1% 98 $461.29
51702 <1% 13 $429.84
84100 <1% 18 $388.19
81015 <1% 375 $383.85
82507 <1% 17 $285.64
82131 <1% 17 $275.64
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 12 $271.01
J0780 Injection, prochlorperazine, up to 10 mg <1% 33 $264.10
A9537 Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries <1% 18 $262.46
83945 <1% 17 $253.65
J7050 Infusion, normal saline solution, 250 cc <1% 87 $240.16
82248 <1% 14 $238.69
83935 <1% 17 $233.70
86430 <1% 14 $195.85
C1758 Catheter, ureteral <1% 38 $178.40
82340 <1% 30 $168.52
82009 <1% 14 $153.96
J1630 Injection, haloperidol, up to 5 mg <1% 45 $153.04
J2470 Injection, pantoprazole sodium, 40 mg <1% 27 $151.84
84133 <1% 17 $149.82
J1650 Injection, enoxaparin sodium, 10 mg <1% 31 $147.22
84300 <1% 17 $143.82
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 229 $138.39
80069 <1% 23 $129.24
82436 <1% 17 $127.82
84560 <1% 17 $121.82
94664 <1% 93 $110.69
84105 <1% 17 $103.83
84392 <1% 17 $83.88
J0690 Injection, cefazolin sodium, 500 mg <1% 16 $72.80
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 16 $35.06
J2003 Injection, lidocaine hydrochloride, 1 mg <1% 46 $35.04
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting <1% 12 $3.05
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting <1% 332 $0.63
A9270 Non-covered item or service 0% 45 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialZIMMERMAN, DOROTHY (SENIOR DIRECTOR)
Parent organizationSAINT JOSEPH HEALTH SYSTEM, INC